Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Sung JIn Yoon, RN
CONTACT
Tak Yun, M.D.
CONTACT
Lead
National Cancer Center, Korea
With
The investigators are conducting a phase I/II study to determine the maximum-tolerated dose, the recommended dose, and to evaluate the response rate and toxicity of the TS-1, irinotecan and cisplatin combination in patients with advanced or metastatic NSCLC.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted